Diastolic heart failure, now more commonly called heart failure with preserved ejection fraction (HFpEF), progresses through four stages labeled A through D. These stages were developed by the American College of Cardiology and American Heart Association to describe how the condition evolves from early risk factors all the way to advanced disease. Unlike a functional classification that measures how symptoms limit your daily activity, the staging system tracks the actual progression of the disease in your body, and importantly, you can only move forward through the stages, never backward.
In diastolic heart failure, the heart pumps with normal force (an ejection fraction above 40%) but the left ventricle has become stiff and doesn’t relax properly between beats. This means less blood fills the heart during its resting phase, leading to fluid backup and the classic symptoms of heart failure: shortness of breath, fatigue, and swelling.
Stage A: At Risk
Stage A applies to people who have no symptoms and no structural changes in the heart yet, but carry risk factors that make diastolic heart failure more likely down the road. The biggest contributors are high blood pressure, diabetes, obesity, and coronary artery disease. Chronic kidney disease and a family history of heart failure also qualify.
At this stage, the goal is entirely preventive. Managing blood pressure, maintaining a healthy weight, staying physically active, and controlling blood sugar can keep the heart’s structure from changing in the first place. Many people in Stage A never progress further if these risk factors are addressed early enough. This is the only stage where the condition can realistically be stopped before it starts.
Stage B: Pre-Heart Failure
Stage B marks the point where the heart has begun to change structurally, but you still feel fine. There are no symptoms of heart failure. What distinguishes Stage B from Stage A is evidence of structural heart disease or increased filling pressures in the heart, even though these changes haven’t yet caused noticeable problems.
For diastolic heart failure specifically, this often means the walls of the left ventricle have thickened (a condition called left ventricular hypertrophy), usually in response to years of high blood pressure forcing the heart to work harder. The thickened muscle is stiffer and doesn’t stretch as easily, setting the stage for impaired filling. These changes are typically detected on an echocardiogram or through elevated levels of a blood marker called NT-proBNP. Values above 125 pg/mL in people over 75, for instance, correlate with increased risk of future heart failure hospitalization.
Treatment at this stage focuses on the same risk factor management as Stage A, with closer monitoring and sometimes medication to address the structural changes that have already occurred.
Stage C: Symptomatic Heart Failure
Stage C is where most people first learn they have diastolic heart failure, because this is when symptoms appear. Shortness of breath during physical activity, fatigue, swelling in the legs or ankles, and difficulty lying flat are the hallmarks. Some people notice these symptoms only during exertion, while others experience them with minimal activity or even at rest.
For years, treatment options at this stage were limited mainly to diuretics (water pills) to reduce fluid buildup. That changed significantly around 2020 when two large clinical trials showed that a newer class of medications, SGLT2 inhibitors (originally developed for diabetes), reduced cardiovascular death and heart failure hospitalizations in people with HFpEF. These drugs currently carry a strong recommendation in treatment guidelines for this condition.
Your doctor may also use tools to monitor fluid levels more precisely. Implantable pulmonary artery pressure monitors, for example, allow real-time tracking of pressure changes inside the heart, helping guide diuretic adjustments before fluid buildup becomes severe enough to send you to the hospital. This technology received FDA approval specifically for heart failure management.
Beyond medication, Stage C management involves sodium restriction, regular physical activity tailored to your tolerance, and careful attention to daily weight changes, since sudden weight gain often signals fluid retention before you feel other symptoms.
Stage D: Advanced Heart Failure
Stage D represents the most severe form of the disease. At this point, symptoms are persistent and significantly limit daily life despite maximum medical treatment. People in Stage D often experience breathlessness at rest, extreme fatigue, and repeated hospitalizations. Two or more heart failure hospitalizations within a year is one of the key markers that the disease has reached this stage.
Treatment options narrow considerably. The focus shifts toward optimizing all existing therapies, managing fluid status aggressively, and addressing other health conditions that worsen heart failure. For some patients with reduced ejection fraction, heart transplantation or mechanical heart pumps are options, but these are less commonly available for diastolic heart failure because the pumping function itself remains relatively intact. The core problem, a stiff heart that won’t relax, is harder to fix mechanically.
Palliative care becomes an important part of the conversation at Stage D. This doesn’t necessarily mean end-of-life care. Palliative specialists focus on symptom relief and quality of life, which matters enormously when standard treatments are no longer controlling symptoms well. Clinicians should discuss goals of care openly at this stage, including what level of intervention you want going forward and whether devices like implantable defibrillators still align with your wishes.
How the Stages Differ From Functional Classes
You may also encounter the NYHA functional classification system, which uses Classes I through IV. This is a separate system that describes how much your symptoms limit your physical activity on any given day. Class I means no limitations, Class II means mild limitations during ordinary activity, Class III means significant limitations where only light activity is comfortable, and Class IV means symptoms at rest.
The critical difference is that functional class can improve or worsen with treatment, a bad week, or a change in medication. The ACC/AHA stages cannot go backward. Once your heart has developed structural changes (Stage B), you remain at Stage B or higher permanently, even if you feel great. A person in Stage C who responds well to treatment might function like NYHA Class I on most days, but they’re still Stage C because they have structural disease and a history of symptoms. Both systems are useful, but the staging system better captures the underlying reality of how far the disease has progressed in your body.
How Diastolic Heart Failure Is Diagnosed
Because the heart’s pumping strength looks normal on standard tests, diastolic heart failure can be tricky to diagnose. An echocardiogram showing an ejection fraction above 40% combined with evidence of impaired relaxation or elevated filling pressures is the cornerstone. Blood tests for NT-proBNP add supporting evidence: levels above 600 pg/mL are strong predictors of restrictive filling patterns in the heart, while concentrations above 400 pg/mL are associated with significantly higher cardiovascular risk.
However, NT-proBNP levels in HFpEF can sometimes be deceptively normal, particularly in people who are obese or in early stages of the disease. This is one reason the condition is frequently underdiagnosed or caught only after symptoms have been present for months or years.